Cypress Capital Management (Delaware) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$13.4M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$6.4M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$3.92M |
| 4 |
AstraZeneca
AZN
|
+$3.29M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$3.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$8.14M |
| 2 |
Pinnacle West Capital
PNW
|
+$7M |
| 3 |
GE Aerospace
GE
|
+$4.79M |
| 4 |
Ingredion
INGR
|
+$1.03M |
| 5 |
Vanguard Information Technology ETF
VGT
|
+$749K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.31% |
| 2 | Healthcare | 14.22% |
| 3 | Financials | 9.7% |
| 4 | Consumer Discretionary | 9.52% |
| 5 | Communication Services | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
CVS Health
CVS
$122B
| $224K | 0.03% |
+2,175
| New | +$201K |
|
202
Marriott Vacations Worldwide
VAC
$4.25B
| $223K | 0.03% |
+1,320
| New | +$212K |
|
203
M&T Bank
MTB
$36.2B
| $222K | 0.03% |
1,445
| – | – |
|
204
SPDR Gold Trust
GLD
$142B
| $215K | 0.02% |
1,260
| – | – |
|
|
HDV
205
iShares Core High Dividend ETF
HDV
$14.8B
| $215K | 0.02% |
10,650
+250
| +2% | +$4.9K |
|
206
Cigna
CI
$74.6B
| $209K | 0.02% |
909
| – | – |
|
207
SIGA Technologies
SIGA
$219M
| $94K | 0.01% |
12,500
| – | – |
|
|
208
Intel
INTC
$513B
| – | – |
-145,082
| Closed | -$8.14M |
|
209
Organon & Co
OGN
$3.57B
| – | – |
-22,850
| Closed | -$691K |
|
|
210
Pinnacle West Capital
PNW
$12.2B
| – | – |
-85,390
| Closed | -$7M |
|
Similar funds
Cypress Capital Management (Delaware)'s Q4 2021 Portfolio in Review
As of Q4 2021, Cypress Capital Management (Delaware) held 210 positions worth $884M, up 17% from $757M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Cypress Capital Management (Delaware) deployed $52M of net new capital in Q4 2021, opening 37 new positions and adding to 75 existing holdings. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 164,433 shares worth $13.4M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was GE Aerospace, an estimated $4.79M trimmed.
- Cypress Capital Management (Delaware)'s largest Q4 2021 buy was Vanguard Short-Term Corporate Bond ETF: 164,433 shares worth $13.4M.
- Cypress Capital Management (Delaware) added most to AstraZeneca in Q4 2021, an estimated $3.29M increase.
- Cypress Capital Management (Delaware)'s biggest Q4 2021 reduction was GE Aerospace, cutting an estimated $4.79M.
- Cypress Capital Management (Delaware) fully exited Intel in Q4 2021, selling an estimated $8.14M.
- Cypress Capital Management (Delaware)'s ten largest holdings make up 28% of its $884M portfolio in Q4 2021.
- Cypress Capital Management (Delaware) opened 37 new positions and closed 3 in Q4 2021.
- Cypress Capital Management (Delaware)'s portfolio value rose 17% quarter-over-quarter to $884M.
Based on Cypress Capital Management (Delaware)'s 13F filing for Q4 2021, filed 22 Feb 2022.